The FDA’s Circulatory System Devices Panel voted 7-5 in favor of the Watchman, an implantable device that blocks the left atrial appendage with a fabric-covered expandable nitinol cage. It is designed to help patients with nonvalvular AF avoid warfarin therapy.
You can read a Heartwire story, a MedPage story, or a Reuters story.
You can read links to additonal coverage about the device in our previous story.
Pingback: WATCHMAN: will it replace warfarin in some patients? « CardioBrief
Pingback: FDA: Watchman device will need to wait a bit longer « CardioBrief
Pingback: Late-Breaking News: Confusion Over ACC Late-Breaker Trial « CardioBrief